| L01CD01,L03AA02 |
Filgrastim |
Tevagrastim 30 MIU/0,5 ml solution for injection or infusion |
Solution for injection/infusion |
0.3 |
mg |
1 |
Teva GmBH, Германия |
0.35 |
mg |
83.33 |
70.56177 |
60.68 |
100% |
|
Съгласно РУ |
; НСР-9321/16.05.2016 |
02.07.2016 |
08.09.2012 |
Заличен |
1362 |
| L01CD01,L03AA02 |
Filgrastim |
Tevagrastim 48 MIU/0,8 ml solution for injection or infusion |
Solution for injection/infusion |
0.48 |
mg |
5 |
Teva Generics GmbH, Германия |
0.35 |
mg |
622.43 |
82.21208 |
563.74 |
100% |
|
Съгласно РУ |
КЦРР-1287/21.08.2012 г.; НСР-1802/25.11.2013; НСР-3571/23.05.2014 |
16.06.2014 |
08.09.2012 |
Заличен |
2303 |
| L01CD01,L03AA02 |
Filgrastim |
Tevagrastim 48 MIU/0,8 ml solution for injection or infusion |
Solution for injection/infusion |
0.48 |
mg |
1 |
Teva Generics GmbH, Германия |
0.35 |
mg |
133.32 |
82.21208 |
112.75 |
100% |
|
Съгласно РУ |
КЦРР-1287/21.08.2012 г.; НСР-3571/23.05.2014 |
16.06.2014 |
08.09.2012 |
Заличен |
1363 |
| L03AA02 |
Filgrastim |
Zarzio |
Solution for injection/infusion |
30 MU (60 MU/ml) - 0,5 ml |
|
5 pre-filled syringes with needle safety guard |
Sandoz GmbH, Австрия |
0.35 |
mg |
329.39 |
70.56177 |
302.71 |
100% |
|
Съгласно РУ |
№ 197/ 19.09.2011; НСР-115/07.06.2013; НСР-2895/05.03.2014.; НСР-6414/12.06.2015. |
16.11.2015 |
08.09.2012 |
Активен |
2598 |
| L03AA02 |
Filgrastim |
Zarzio |
Solution for injection/infusion |
48 MU/ 0,5 ml |
mg |
5 |
Sandoz GmbH, Австрия |
0.35 |
mg |
453.8 |
66.1516 |
453.8 |
100% |
|
Съгласно РУ |
№ 197/ 19.09.2011; НСР-115/07.06.2013; НСР-2895/05.03.2014.; НСР-6413/12.06.2015.; НСР-6863/30.07.2015. |
02.09.2015 |
08.09.2012 |
Заличен |
2599 |
| L03AA10 |
Lenograstim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AA10 |
Lenograstim |
Granocyte |
Powder and solvent for solution for injection |
33.6 MIU + 1 ml solv. (1 fl. = 263 mcg) |
mg |
5 |
Санофи-Авентис България ЕООД, България |
0.35 |
mg |
525.9 |
139.97871 |
525.9 |
100% |
|
Съгласно РУ |
НСР-1655/11.11.2013; НСР-4044/03.07.2014; НСР-4451/15.08.2014 .; НСР-7955/08.02.2016. |
02.03.2016 |
08.09.2012 |
Заличен |
3150 |
| L03AA13 |
Pegfilgrastim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AA13 |
Pegfilgrastim |
Neulasta solution for injection pre-filled syringe 10 mg/ ml |
|
6 |
mg |
1 |
Amgen Eurоpe B.V., Нидерландия |
0.3 |
mg |
1717.51 |
85.8755 |
1717.51 |
100% |
|
Съгласно РУ |
№ 238/ 04.11.2011; КЦРР-1872/15.12.2012 г; НСР-4168/23.07.2014 |
16.08.2014 |
08.09.2012 |
Заличен |
1513 |
| L03AA13 |
Pegfilgrastim |
Neulasta solution for injection pre-filled syringe with needle guard 10 mg/ ml |
|
6 |
mg |
1 |
Amgen Eurоpe B.V., Нидерландия |
0.3 |
mg |
1648.96 |
82.448 |
1648.96 |
100% |
|
Съгласно РУ |
КЦРР-1575/05.11.2012 г.; НСР-5301/ 18.12.2014; НСР-7291/29.10.2015 |
02.12.2015 |
|
Активен |
3475 |
| L03AA14 |
Lipegfilgrastim |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AA14 |
Lipegfilgrastim |
Lonquex |
Solution for injection |
6 mg/0,6 ml |
|
1 pre-filled syringe with safety device |
UAB "Sicor Biotech", V. A., Литва |
0.3 |
mg |
1678.37 |
83.9185 |
1678.37 |
100% |
|
Съгласно РУ |
НСР-3771/16.06.2014; НСР-7482/12.11.2015 |
02.12.2015 |
|
Активен |
2930 |
| L03AB |
Interferon beta |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB08 |
Interferon beta-1b |
Betaferon |
Powder and solvent for solution for injection |
9.6 |
MIU |
15 vials + 15 pre-filled syringe |
Bayer Pharma AG, Германия |
4 |
MIU |
1444.37 |
39.67233 |
1190.17 |
100% |
|
Съгласно РУ |
; НСР-9117/27.04.2016 |
02.06.2016 |
08.09.2012 |
Активен |
3629 |
| L03AB08 |
Interferon beta-1b |
Extavia |
Powder and solvent for solution for injection |
9.6 |
MIU |
15 |
Novartis Europharm Limited, Обединено Кралство |
4 |
MIU |
1190.17 |
39.67233 |
1190.17 |
100% |
|
Съгласно РУ |
№ 178/ 22.06.2011; КЦРР-2188/06.02.2013 г; НСР-1733/21.11.2013; НСР-4537/22.08.2014; НСР-7473/12.11.2015 |
02.12.2015 |
08.09.2012 |
Активен |
3155 |
| L03AB04 |
Interferon alfa-2a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB04 |
Interferon alfa-2a |
Roferon-A |
solution for injection / pre-filled syringe + needle |
3 |
MIU |
1 |
Рош България ЕООД, България |
2 |
MIU |
23.94 |
15.96 |
23.94 |
100% |
|
Съгласно РУ |
КЦРР-924/04.07.2012 г. КЦРР-1418/05.09.2012;НСР-516/11.07.2013; НСР-2936/07.03.2014; Протокол 82/11.09.2014; НСР-5073/21.11.2014; НСР-6840/30.07.2015. |
02.09.2015 |
08.09.2012 |
Активен |
3362 |
| L03AB05 |
Interferon alfa - 2b |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB05 |
Interferon Alfa-2b |
Realdiron |
Powder for solution for injection |
3 |
MIU |
5 |
Sicor Biotech UAB, Литва |
2 |
MIU |
76.4 |
10.18667 |
76.4 |
100% |
|
Съгласно РУ |
НСР-3216/14.04.2014 |
16.05.2014 |
08.09.2012 |
Заличен |
660 |
| L03AB10 |
Peginterferon |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
120 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
399.74 |
24.7095 |
395.35 |
100% |
|
Съгласно РУ |
№35/21.08.2009; №39/27.08.2009; КЦPP-1635/15.11.2012; КЦРР-2283/20.02.2013 г; НСР-1977/06.12.2013; НСР-4302/05.08.2014; НСР-5830/19.03.2015; НСР-9397/01.06.2016 |
02.07.2016 |
08.09.2012 |
Активен |
3694 |
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
80 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
270.61 |
24.7095 |
263.57 |
100% |
|
Съгласно РУ |
№35/21.08.2009; №39/27.08.2009; КЦPP-1149/02.08.2012; КЦРР-2285/20.02.2013 г; НСР-1977/06.12.2013; НСР-4300/05.08.2014; НСР-5829/19.03.2015; НСР-9398/01.06.2016 |
02.07.2016 |
08.09.2012 |
Активен |
3695 |
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
150 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
503.14 |
24.7095 |
494.19 |
100% |
|
Съгласно РУ |
КЦPP-2419/22.02.2013; НСР-5063/18.11.2014; НСР-8251/22.02.2016 |
02.04.2016 |
|
Активен |
3366 |
| L03AB10 |
peginterferon alfa-2b |
PegIntron |
Powder and solvent for solution for injection |
100 mcg/0,5 ml |
|
1 pen (pre-filled pen (cartridge, glass) + 1 injection needle + 2 cleansing swabs |
Merck Sharp & Dohme Ltd., Обединено Кралство |
7.5 |
mсg |
329.46 |
24.7095 |
329.46 |
100% |
|
Съгласно РУ |
№35/21.08.2009; №39/27.08.2009; КЦPP-1149/02.08.2012; КЦРР-2284/20.02.2013 г; НСР-1977/06.12.2013; НСР-4301/05.08.2014 |
02.09.2014 |
08.09.2012 |
Активен |
3140 |
| L03AB11 |
Peginterferon alfa-2a |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|